0078 (0078) Fair Value & Analysis

Consumer Cyclical · Market cap HK$360M

0 0078 0078 · HK

PriceHK$0.4000

Fair ValueHK$0.3697

Upside-7.6%

Quality51/100

Evidence: Medium Range HK$0.1787 – HK$0.6966

Fair value as of: Jul 1, 2026

From 12 valuation models · updated today

Share price −25.9% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.4000 – HK$0.7000 · fair‑value band HK$0.1787 – HK$0.6966 · the HK$0.4000 price screens above the HK$0.3697 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0078 (0078) currently trades at HK$0.4000, while our model-based Fair Value estimate is HK$0.3697 — implying the stock looks roughly 7.6% overvalued today. We read business quality at 51/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 0078 generated revenue of HK$2.5B at a net margin of -48.5%. Revenue grew 151.5% year over year. It earns a return on equity of -17.2%. Net debt stands at HK$15.9B. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$2.5B

Revenue growth (YoY) +152%

Net margin -48.5%

Return on equity -17.2%

Free cash flow HK$1.3B FY2025

Operating margin -10.7%

More key figures

EPS (TTM) HK$-0.8200

EPS growth (YoY) +72.6%

Net debt HK$15.9B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0078 reported revenue of HK$2.8B in FY2025 versus HK$987M in FY2021, a compound +29.3%/yr. Reported net income was −HK$1.2B in FY2025.

Revenue +29.3%/yr

FY21 HK$987M

FY22 HK$1.8B

FY23 HK$1.8B

FY24 HK$1.8B

FY25 HK$2.8B

Net income

FY21 −HK$494M

FY22 −HK$473M

FY23 −HK$1.8B

FY24 −HK$2.6B

FY25 −HK$1.2B

Is 0078 fairly valued? → Check now

Similar stocks

6 more Lodging stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
Marriott International, Inc MAR	$386.23	$94.01	-76%
Hilton Worldwide Holdings HLT	$342.93	$123.66	-64%
InterContinental Hotels Group IHG	$170.05	$85.18	-50%
Hyatt Hotels Corporation H	$190.63	$54.44	-71%
H World Group H1TH34	R$62.64	R$83.92	+34%
Accor SA ACRFF	$57.35	$44.53	-22%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0078 (0078) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$0.3697 versus a price of HK$0.4000 — about −8% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0078?

Our model-based fair value for 0078 is HK$0.3697 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$0.4000.

What is the quality score of 0078?

0078 has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0078 (0078)?

0078 reported trailing-twelve-month revenue of about HK$2.5B (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0078?

The net profit margin of 0078 is about -48.5%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.